A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
NCT01140737
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
145
Enrollment
OTHER
Sponsor class
Conditions
Soft Tissue Sarcoma
Interventions
DRUG:
Axitinib
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Collaborators
[object Object]
[object Object]
[object Object]